Avalo Therapeutics (AVTX) FCF Margin Growth (3y) (2019 - 2025)
Avalo Therapeutics (AVTX) FCF Margin Growth (3y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15,064.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 723.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1,409.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Avalo Therapeutics | 1.04 Mn | 1.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.38 Mn |
| Dec 31, 2024 | -48,428.00 |
| Sep 30, 2024 | -327,606.00 |
| Dec 31, 2023 | 48,005.00 |
| Sep 30, 2023 | -182,820.00 |
| Jun 30, 2023 | -107,539.00 |
| Mar 31, 2023 | -194,109.00 |
| Dec 31, 2022 | -40,829.00 |
| Sep 30, 2022 | 38,486.00 |
| Jun 30, 2022 | -72,628.00 |
| Mar 31, 2022 | -124,213.00 |
| Dec 31, 2021 | -739,034.00 |
| Sep 30, 2021 | -133,909.00 |
| Jun 30, 2021 | -56,478.00 |
| Mar 31, 2021 | -387,006.00 |
| Dec 31, 2020 | -83,027.00 |
| Sep 30, 2020 | -114,476.00 |
| Jun 30, 2020 | 47,535.00 |
| Mar 31, 2020 | 37,418.00 |
| Dec 31, 2019 | 200,312.00 |